Rescuing BMPR2-driven endothelial dysfunction in PAH: a novel treatment strategy for the future?
- PMID: 28725652
- PMCID: PMC5503913
- DOI: 10.21037/sci.2017.05.11
Rescuing BMPR2-driven endothelial dysfunction in PAH: a novel treatment strategy for the future?
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers.Cell Stem Cell. 2017 Apr 6;20(4):490-504.e5. doi: 10.1016/j.stem.2016.08.019. Epub 2016 Dec 22. Cell Stem Cell. 2017. PMID: 28017794 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous